ATA947076A - Verfahren zur herstellung neuer ergolinderivate - Google Patents

Verfahren zur herstellung neuer ergolinderivate

Info

Publication number
ATA947076A
ATA947076A AT0947076A AT947076A ATA947076A AT A947076 A ATA947076 A AT A947076A AT 0947076 A AT0947076 A AT 0947076A AT 947076 A AT947076 A AT 947076A AT A947076 A ATA947076 A AT A947076A
Authority
AT
Austria
Prior art keywords
producing new
derivatives
ergol derivatives
new ergol
producing
Prior art date
Application number
AT0947076A
Other languages
English (en)
Other versions
AT367762B (de
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to AT0947076A priority Critical patent/AT367762B/de
Priority to AT759579A priority patent/AT376221B/de
Priority to AT759479A priority patent/AT370102B/de
Publication of ATA947076A publication Critical patent/ATA947076A/de
Application granted granted Critical
Publication of AT367762B publication Critical patent/AT367762B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06Lysergic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0947076A 1975-12-23 1976-12-21 Verfahren zur herstellung neuer ergolinderivate AT367762B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT0947076A AT367762B (de) 1976-12-21 1976-12-21 Verfahren zur herstellung neuer ergolinderivate
AT759579A AT376221B (de) 1975-12-23 1979-11-30 Verfahren zur herstellung neuer ergolinderivate
AT759479A AT370102B (de) 1975-12-23 1979-11-30 Verfahren zur herstellung neuer ergolinderivate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0947076A AT367762B (de) 1976-12-21 1976-12-21 Verfahren zur herstellung neuer ergolinderivate

Publications (2)

Publication Number Publication Date
ATA947076A true ATA947076A (de) 1981-12-15
AT367762B AT367762B (de) 1982-07-26

Family

ID=3614428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0947076A AT367762B (de) 1975-12-23 1976-12-21 Verfahren zur herstellung neuer ergolinderivate

Country Status (1)

Country Link
AT (1) AT367762B (de)

Also Published As

Publication number Publication date
AT367762B (de) 1982-07-26

Similar Documents

Publication Publication Date Title
AT366361B (de) Verfahren zur herstellung neuer 2-aminotetraline
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT351510B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
ATA60577A (de) Verfahren zur herstellung neuer polypeptidderivate
ATA151981A (de) Verfahren zur herstellung neuer benzopyranderivate
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
AT352918B (de) Verfahren zur herstellung neuer histidin- derivate
DD132438A5 (de) Verfahren zur herstellung neuer kortikoide
DD134641A5 (de) Verfahren zur herstellung neuer sulfamoylbenzoesaeuren
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
ATA736576A (de) Verfahren zur herstellung neuer indolderivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT360971B (de) Verfahren zur herstellung neuer alkinole
DD133331A5 (de) Verfahren zur herstellung neuer basischer substituierter theophyllinderivate
AT364826B (de) Verfahren zur herstellung neuer morphinanderivate
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
DD131169A5 (de) Verfahren zur herstellung neuer azatetracyclen
AT372386B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
ATA947076A (de) Verfahren zur herstellung neuer ergolinderivate
DD134765A5 (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
AT365606B (de) Verfahren zur herstellung neuer 1,6-anhydro-beta- d-hexopyranosederivate
AT355239B (de) Verfahren zur herstellung neuer d-homosteroide

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee